Radioactive antibody seeks and shows Hard-to-Treat cancers
NCT ID NCT07272642
Summary
This early-stage study is testing a new radioactive antibody called LNTH-2403 in people with advanced colorectal, head and neck, lung, or breast cancer. The main goals are to see if a single dose is safe and to use special scans to see where the antibody goes in the body and if it collects in tumors. This research could help develop a new way to both find and potentially treat certain cancers.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Icon Cancer Centre Hollywood
Nedlands, Western Australia, 6009, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.